Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.

Birnie, Emma; Biemond, Jason J; Appelman, Brent; de Bree, Godelieve J; Jonges, Marcel; Welkers, Matthijs R A; Wiersinga, W Joost

Birnie, Emma; Biemond, Jason J; Appelman, Brent; de Bree, Godelieve J; Jonges, Marcel; Welkers, Matthijs R A; Wiersinga, W Joost.

Birnie E; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Biemond JJ; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Appelman B; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
de Bree GJ; Division of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Jonges M; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Welkers MRA; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.

JAMA ; 328(11): 1104-1107, 2022 09 20.

Статья в английский | MEDLINE | ID: covidwho-2047336

Тема - темы

Полный текст

Печатать

XML

PubMed Links

Search on Google

Полный текст: Имеется в наличии Коллекция: Международные базы данных база данных: MEDLINE Основная тема: Drug Resistance, Viral / Antibodies, Neutralizing / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Тип исследования: Прогностическое исследование Темы: Варианты Пределы темы: Люди Язык: английский Журнал: JAMA Год: 2022 Тип: Статья Аффилированная страна: Jama.2022.13854

Документы, близкие по теме

MEDLINE

LILACS

LIS

Полный текст

Печатать

XML

PubMed Links

Search on Google